{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Pfizer is stepping up its efforts to stop exports of low-price prescription drugs from Canada to the United States by imposing new restrictions on sales to Canadian drug wholesalers. In a letter to Canadian retail pharmacies, Pfizer said that it would immediately require wholesale distributors to report past and present orders of Pfizer products from individual drugstores.", "headline": {"main": "Pfizer Moves to Try to Stop Drugs From Canada"}, "abstract": "Pfizer is stepping up its efforts to stop exports of low-price prescription drugs from Canada to US by imposing new restrictions on sale to Canadian drug wholesalers; says it will immediately require wholesale distributors to report past and present orders of Pfizer products from individual drugstores; Food and Drug Administration has discretion to allow small amounts of drugs to be imported for personal use even though drug imports are banned under US law; growing number of states and municipalities have called for ban to be eased so they can lower drug costs for their employees; pharmaceutical industry, concerned about potential erosion of its biggest market, opposes any relaxation of import ban; Jill McKinlay-Morris, spokesman for GlaxoSmithKline's Canadian unit, says company is strongly against export of its medications; photo (M)", "print_page": "1", "word_count": 620, "_id": "4fd24f0f8eb7c8105d7f1215", "snippet": "Pfizer is stepping up its efforts to stop exports of low-price prescription drugs from Canada to the United States by imposing new restrictions on sales to Canadian drug wholesalers.    In a letter to Canadian retail pharmacies, Pfizer said that it...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/01/14/business/pfizer-moves-to-try-to-stop-drugs-from-canada.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "KINLEY-MORRIS, JILL"}, {"name": "glocations", "value": "CANADA"}, {"name": "glocations", "value": "UNITED STATES"}, {"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "organizations", "value": "GLAXOSMITHKLINE"}, {"name": "organizations", "value": "PFIZER INC"}, {"name": "subject", "value": "STATES (US)"}, {"name": "subject", "value": "INTERNATIONAL TRADE AND WORLD MARKET"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "LAW AND LEGISLATION"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Bernard", "lastname": "SIMON"}], "original": "By BERNARD SIMON"}, "document_type": "article", "pub_date": "2004-01-14T00:00:00Z", "section_name": "Health; Business"}, {"type_of_material": "News", "blog": [], "news_desk": "Health & Fitness", "lead_paragraph": "Americans are about to be reminded again how much they need sleep -- and sleeping pills. A new effort appears to be developing to expand the use of sleeping pills, which because of their potential for abuse have long had a reputation as being in some ways more dangerous than the insomnia they are meant to treat.", "headline": {"main": "Putting a Price on a Good Night's Sleep"}, "abstract": "Estimated 10 to 15 percent of adults have chronic insomnia and many sleep experts support new effort to expand use of sleeping pills; hold that insomnia is serious medical condition, not just nuisance, and untreated does have associated health risks; Gary A Lyons, Neurocrine Biosciences president and chief executive, contends that sleep inducing drugs are one of largest potential pharmaceutical markets worldwide; Neurocrine has developed new drug indiplon for Pfizer; drug should be available by end of 2005; history of sleeping pills described; Dr Daniel F Kripke, University of California (San Diego) psychiatry professor, believes use of sleeping pills is only beneficial for those seeking financial gain such as scientists and drug companies and holds that use of pills can be detrimental to those wanting to improve sleep; National Institutes of Health is expected to develop new consensus statement in next year or two about insomnia and treatment that should help doctors determine best course of action for those suffering from chronic insomnia; photos (L)", "print_page": "1", "word_count": 1992, "_id": "4fd24bba8eb7c8105d7ead73", "snippet": "Americans are about to be reminded again how much they need sleep -- and sleeping pills.    A new effort appears to be developing to expand the use of sleeping pills, which because of their potential for abuse have long had a reputation as being in...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/01/13/health/putting-a-price-on-a-good-night-s-sleep.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "KRIPKE, DANIEL F"}, {"name": "persons", "value": "LYONS, GARY A"}, {"name": "organizations", "value": "NEUROCRINE BIOSCIENCES INC"}, {"name": "organizations", "value": "PFIZER INC"}, {"name": "organizations", "value": "NATIONAL INSTITUTES OF HEALTH"}, {"name": "organizations", "value": "UNIVERSITY OF CALIFORNIA"}, {"name": "subject", "value": "INDIPLON (DRUG)"}, {"name": "subject", "value": "INTERNATIONAL TRADE AND WORLD MARKET"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "FINANCES"}, {"name": "subject", "value": "SLEEP"}, {"name": "subject", "value": "DOCTORS"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "INSOMNIA"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Andrew", "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2004-01-13T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Tommy G. Thompson, the secretary of health and human services, said Monday that elderly people were forming negative impressions of the new Medicare law, and he blamed Democratic presidential candidates, who he said were spreading misinformation about the measure, championed by President Bush. ''There's a lot of misinformation out there,'' Mr. Thompson said at a briefing for reporters, complaining that ''just about every one of the Democrat candidates running for president has been criticizing the Medicare law.''", "headline": {"main": "Health Chief Attacks Democrats on Medicare"}, "abstract": "Tommy G Thompson, secretary of health and human services, says elderly people are forming negative impressions of new Medicare law because Democratic presidential candidates are spreading misinformation about measure, which was championed by Pres Bush; summarizes and rejects Democratic arguments about bill (M)", "print_page": "23", "word_count": 614, "_id": "4fd27aa08eb7c8105d83ef09", "snippet": "Tommy G. Thompson, the secretary of health and human services, said Monday that elderly people were forming negative impressions of the new Medicare law, and he blamed Democratic presidential candidates, who he said were spreading misinformation...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/01/13/us/health-chief-attacks-democrats-on-medicare.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "THOMPSON, TOMMY G"}, {"name": "persons", "value": "BUSH, GEORGE W"}, {"name": "glocations", "value": "UNITED STATES"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "ELECTION ISSUES"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "LAW AND LEGISLATION"}, {"name": "subject", "value": "PRESIDENTIAL ELECTION OF 2004"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Robert", "lastname": "PEAR"}], "original": "By ROBERT PEAR"}, "document_type": "article", "pub_date": "2004-01-13T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "New Jersey Weekly Desk", "lead_paragraph": "LYNN'S arms are a map of addiction. Her skin is pocked by needle marks, scored by more than a decade of abuse. Small knots of scar tissue cover the thin lines of her veins; a jagged patch of missing flesh marks a runaway infection and a surgeon's knife. A fresh needle track burns dead center, a glowing purple reminder of the drug that is the defining feature of her life.", "headline": {"main": "It's Not the Heroin, It's the Needle"}, "abstract": "Article on unsuccessful efforts to pass legislation in New Jersey that would provide access to clean syringes for illegal drug users; Health Department reports there are currently 61,698 people infected with HIV virus in state and 45,256 people with full-blown AIDS; State Sen Joseph Vitale, Democrat from Woodbridge who sponsored unsuccessful bill, says New Jersey is dancing on edge of public health disaster; photos (M)", "print_page": "1", "word_count": 2897, "_id": "4fd24bbd8eb7c8105d7eb08e", "snippet": "LYNN'S arms are a map of addiction.      Her skin is pocked by needle marks, scored by more than a decade of abuse. Small knots of scar tissue cover the thin lines of her veins; a jagged patch of missing flesh marks a runaway infection and a...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/01/11/nyregion/it-s-not-the-heroin-it-s-the-needle.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "VITALE, JOSEPH"}, {"name": "glocations", "value": "NEW JERSEY"}, {"name": "subject", "value": "HEROIN"}, {"name": "subject", "value": "ACQUIRED IMMUNE DEFICIENCY SYNDROME"}, {"name": "subject", "value": "HYPODERMIC NEEDLES AND SYRINGES"}, {"name": "subject", "value": "LAW AND LEGISLATION"}, {"name": "subject", "value": "DRUG ABUSE AND TRAFFIC"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "John", "lastname": "SULLIVAN"}], "original": "By JOHN SULLIVAN"}, "document_type": "article", "pub_date": "2004-01-11T00:00:00Z", "section_name": "New York and Region"}, {"type_of_material": "News", "blog": [], "news_desk": "Money and Business/Financial Desk", "lead_paragraph": "THERE are a couple of questions that few people seem to be asking about the limited Medicare prescription drug law that goes into effect in 2006: What impact will it have on pharmaceutical companies' programs that offer free drugs to low-income people, including those on Medicare?", "headline": {"main": "Two Holes in the Medicare Drug Law", "kicker": "SENIORITY"}, "abstract": "Fred Brock column on limited Medicare prescription drug law that goes into effect in 2006; discusses its possible impact on pharmaceutical companies' programs that offer free drugs to low-income people, including those on Medicare; questions law's prohibition against beneficiaries' buying private insurance to cover considerable gaps in coverage (M)", "print_page": "8", "word_count": 960, "_id": "4fd27aa58eb7c8105d83f331", "snippet": "THERE are a couple of questions that few people seem to be asking about the limited Medicare prescription drug law that goes into effect in 2006:     What impact will it have on pharmaceutical companies' programs that offer free drugs to low-income...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/01/11/business/seniority-two-holes-in-the-medicare-drug-law.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "UNITED STATES"}, {"name": "subject", "value": "HEALTH INSURANCE AND MANAGED CARE"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "LAW AND LEGISLATION"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Fred", "lastname": "BROCK"}], "original": "By FRED BROCK"}, "document_type": "article", "pub_date": "2004-01-11T00:00:00Z", "section_name": "Health; Business"}], "meta": {"hits": 5, "offset": 0, "time": 44}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}